Metagenomi Therapeutics, Inc. (MGX) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-10 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-05-11 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-01 | 8-K | Material Agreement, Termination of Agreement | SEC |
| 2025-08-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-11 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-14 | 8-K | Other Events | SEC |
| 2025-05-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-01-16 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-10 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-01 | 8-K | Termination of Agreement, Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-13 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.